Business Description
Vaxxinity Inc. is a US-based biotechnology company founded in 2021 and headquartered in Merritt Island, Florida, that develops medicines targeting serious conditions including Alzheimer's disease, Parkinson's disease, high cholesterol, migraines, and COVID-19. The company has several treatments at various stages of clinical testing, ranging from early-phase trials to a late-stage COVID-19 vaccine candidate. Its approach centers on training the body's immune system to neutralize harmful proteins linked to these diseases.